ADMINISTRATION SITE JOINT ERYTHEMA

This adverse event was reported 8 times

ADMINISTRATION SITE JOINT ERYTHEMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SOLBAR ZINC SPF38 1 0.5000
1 ZAFIRLUKAST 1 0.0011
2 AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE 1 0.0002
3 PEGFILGRASTIM 1 0.0001
4 AMOXICILLIN 4 0.0001
5 HUMAN IMMUNOGLOBULIN G 1 0.0000
6 EPINEPHRINE 1 0.0000
7 PACLITAXEL 1 0.0000
8 CARBOPLATIN 1 0.0000
9 DIPHENHYDRAMINE HYDROCHLORIDE 1 0.0000
See all drugs enriched for association with ADMINISTRATION SITE JOINT ERYTHEMA

ADMINISTRATION SITE JOINT ERYTHEMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 1 0.0000
1 Leukotriene Receptor Antagonist [EPC] 1 0.0000
2 Catecholamine [EPC] 1 0.0000
3 Amide Local Anesthetic [EPC] 1 0.0000
4 Antiarrhythmic [EPC] 1 0.0000
5 Leukocyte Growth Factor [EPC] 1 0.0000
6 Microtubule Inhibitor [EPC] 1 0.0000
7 Platinum-based Drug [EPC] 1 0.0000
8 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000
See all drug classes enriched for association with ADMINISTRATION SITE JOINT ERYTHEMA